This study is looking at how ultrasound pictures of a baby's liver might help predict if newborns of mothers with diabetes will develop jaundice (yellowing of the skin) that needs treatment. Researchers believe that a larger fetal liver (the baby's liver before birth) might lead to higher transcutaneous bilirubin (TcB) levels, which is a measure of jaundice, in the baby after birth. This information could help doctors better advise parents and plan for care. You may be able to join if you are a pregnant woman between 18 and 45 years old with type 1 or type 2 diabetes, carrying one baby, and can give informed consent. The study aims to enroll 156 participants. The study is currently unclear on its recruitment status.

Study design

This is an observational study, meaning researchers will watch and collect information without giving any specific treatments. It is a single-center study, and aims to include 156 participants.

What's involved

If you agree to participate, one ultrasound will be performed between 30-34 weeks of pregnancy. This ultrasound will be done during your regularly scheduled visit, so no extra appointments are needed. After delivery, your baby's health information will be reviewed from their medical chart.

Compensation

Not stated in the trial record.

Follow-up

The study will follow participants and their babies until June 2025 to measure transcutaneous bilirubin (TcB) levels in the newborns.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.